CV Sciences (CVSI) Operating Expenses (2011 - 2026)

CV Sciences has disclosed Operating Expenses across 16 years of filings, most recently posting $806000.0 for Q1 2026.

• Operating Expenses for Q1 2026 came in at $806000.0, down 18.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.7 million (up 61.1% YoY), and the FY2025 annual result was $7.7 million, up 89.53% from the prior year.
• Operating Expenses came in at $806000.0 for Q1 2026 at CV Sciences, down from $5.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $5.1 million in Q4 2025 to a low of $806000.0 in Q1 2026.
• The 5-year median for Operating Expenses is $2.2 million (2023), against an average of $2.2 million.
• Across the five-year window, Operating Expenses sank 64.73% in 2022 and surged 411.86% in 2025, its largest moves.
• CV Sciences' Operating Expenses stood at $3.7 million in 2022, then dropped by 28.64% to $2.6 million in 2023, then slumped by 61.88% to $1.0 million in 2024, then soared by 411.86% to $5.1 million in 2025, then slumped by 84.3% to $806000.0 in 2026.
• The last three Operating Expenses figures came in at $806000.0 (Q1 2026), $5.1 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.